Zobrazeno 1 - 10
of 55
pro vyhledávání: '"William J. Wechter"'
Autor:
Kenneth Hensley, Paula Grammas, Ladan Hamdheydari, Elaine J. Benaksas, Charles A. Stewart, Shenyun Mou, Robert A. Floyd, William J. Wechter, Quentin N. Pye
Publikováno v:
Biochemical and Biophysical Research Communications. 319:1047-1052
Our objective was to assess the anti-inflammatory effects of alpha-tocopherol, gamma-tocopherol, and their metabolites 2,5,7,8-tetramethyl-2-(beta-carboxyethyl)-6-hydroxychroman (alpha-CEHC) and 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman
Autor:
William J. Wechter, Kelly S. Williamson, Elaine J. Benaksas, Paula Grammas, Roberto Bolli, Ladan Hamdheydari, Kenneth Hensley, Marcus F. Stoddard, Melinda West, Robert A. Floyd, Gemma Wallis, Shenyun Mou, Quentin N. Pye
Publikováno v:
Free Radical Biology and Medicine. 36:1-15
Vitamin E (alpha-tocopherol or alphaT) has long been recognized as a classic free radical scavenging antioxidant whose deficiency impairs mammalian fertility. In actuality, alpha-tocopherol is one member of a class of phytochemicals that are distingu
Publikováno v:
Chirality. 16:379-387
Information about the potential and extent of bioinversion of chiral drugs in laboratory animal species and humans is critical to the interpretation of preclinical pharm-tox studies with these drugs. Unlike in the dog, guinea pig, and rabbit, in huma
Autor:
Vijendra K. Singh, Margaret E. Gnegy, S. P. Gupta, R. Leurs, R. C. Vollinga, H. Timmerman, Ray W. Fuller, Nissim Claude Cohen, Vincenzo Tschinke, Elaine J. Benaksas, E. David Murray, William J. Wechter, Indra Dwivedy, Suprabhat Ray
Volume 45 of'Progress in Drug Research'contains eight reviews and the various indexes which facilitate its use and establish the connection with the previous volumes. The articles in this volume deal with neuro peptides as native immune modulators,
Autor:
Karina M. Gibson, E. David Murray, John D. Mccracken, Darko Kantoci, Douglas D. Leipold, David D. Quiggle, William J. Wechter
Publikováno v:
Life Sciences. 66:745-753
Our previous studies with the mouse model of familial adenomatous polyposis (FAP), C57BL/6J-APCMin/+ or Min mouse, demonstrated the optimal dose for adenoma reduction with R-flurbiprofen was 10 mg/kg/day as an undivided dose. Divided doses exhibited
Autor:
Ralph E. Cutler, Kay H. Clifford, Sooky Witchwoot, Steven C. Forland, William J. Wechter, R. Leslie Arnett
Publikováno v:
The Journal of Clinical Pharmacology. 36:546-553
Flurbiprofen, an arylpropionic acid (APA) class nonsteroidal antiinflammatory drug (NSAID), is commercially available only as the racemic mixture, although its pharmacologic effect has been credited primarily to the S isomer. In humans, the bioavaila
Calculation of Inversion Half-Lives of Aryl Propionic Acid Class Nonsteroidal Antiinflammatory Drugs
Autor:
Darko Kantoci, William J. Wechter
Publikováno v:
The Journal of Clinical Pharmacology. 36:500-504
Although inversion of the R-enantiomers of the aryl propionic acid (APA) class of nonsteroidal antiinflammatory drugs (NSAIDs) in humans and other mammals has been known for more than 20 years, no satisfactory method has been developed for evaluating
Autor:
E. David Murray, Youjiang Liu, Darko Kantoci, Resa L. Chase, David D. Quiggle, William J. Wechter, John D. Mccracken, Yoshimitzu Mineyama
Publikováno v:
The Journal of Clinical Pharmacology. 36:540-545
Nonsteroidal antiinflammatory drugs (NSAIDs) are recognized for inhibiting growth of colon tumors in animal models, and for reducing the risk of colon cancer in humans. The mechanisms involved have not been established, but are thought to be related
Publikováno v:
Synthetic Communications. 26:2037-2043
A new facile synthesis of aminobisphosphonate was reported. Dibenzylamine bisphosphonate (1) is prepared from dibenzylamine, triethyl orthoformate and diethyl phosphite. Deprotection by hydrogen transfer reaction and acid hydrolysis afforded aminobis
Publikováno v:
Journal of Medicinal Chemistry. 39:1196-1200
In our search for endogenous natriuretic factors from human uremic urine, we have previously identified a new metabolite of the drug diltiazem (Murray et al. Life Sci. 1995, 57, 2145-2161). The structure of this metabolite, (+)-(2S,3S)-3-hydroxy-5-(2